Skip to main content

Russia's Covid-19 vaccine Sputnik V available to public now: State media

By Unknown

First batches of Russia's Covid vaccine Sputnik V have entered "civil circulation" in capital Moscow, state media reported on Thursday.

While details on the process were not immediately available, Russia has repeatedly stressed on producing the vaccine at the earliest, a belief met with international scepticism.

Earlier this month, the Russian health ministry had said that batches of the Covid-19 vaccine were being produced for public distribution and would be supplied to different regions soon.

"The first batch of the vaccine for preventing the novel coronavirus infection, Gam-COVID-Vac (Sputnik V) developed by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Health Ministry passed the required quality tests in the laboratories of Roszdravnadzor (the Federal Service for Surveillance in Healthcare) and was produced for civilian circulation. In the near future the supplies of the first batches of the vaccine to the regions are expected," the ministry had said.

Russia's Health Minister Mikhail Murashko had previously said that civilian production at this stage meant vaccination of citizens from the risk groups, namely teachers and doctors, which will be carried out simultaneously with post-registration clinical trials.

As the world races to find a cure for coronavirus, vaccine developers around the world are compressing years of development into months, raising the possibility of unexpected consequences.

Developed by Moscow's Gamaleya Institute in collaboration with Russia's sovereign fund RDIF, Sputnik V became the first Covid vaccine candidate in the world to receive government approval for use before completing large-scale human trials.

After receiving regulatory approval amid global concern, the vaccine proceeded with advanced trials.

Large-scale trials of the 'Sputnik-V' vaccine, known as Phase III trials, are ongoing in Russia and involve at least 40,000 people.

"Initial results are expected in October or November, Kirill Dmitriev," head of the Russian Direct Investment Fund (RDIF), has said.

Late-stage clinical trials of the Sputnik V vaccine could also begin in India in the coming weeks as the RDIF has struck a deal with Indian pharmaceutical company Dr Reddy's Laboratories Ltd.

The news of the Sputnik V Covid vaccine entering civil circulation comes as new cases of Covid-19 in Russia have risen to 6,595 on Thursday. This is the biggest rise in over two months, and new infections in Moscow surpassed 1,000 for the first time since late June.

Russia's plan to roll-out its "Sputnik-V" Covid-19 vaccine even before full trials to show how well it works is prompting concern among virus experts, who warn a partially effective shot may encourage the novel coronavirus to mutate.


Comments

Post a Comment

Popular posts from this blog

Increased risks of drop out for women and girls : CoronaVirus Updates

By Unknown
The total number of children not returning to their education after the school closures is likely to be significant. The pandemic also risks jeopardizing some of the gains made since 2001 in re-building women and girls’ education following the Taliban regime.  The COVID-19 pandemic is creating additional barriers due to risks—and students’ and parents’ anxiety about risks—associated with children returning to classrooms that are cramped, with no capacity for distancing, often cold, damp and poorly ventilated during the country’s severe winters, and have no or poor hygiene and clean water facilities. The COVID-19 pandemic is likely to drive many women and girls out of education permanently. School closures due to COVID-19, resulting increases in caregiving responsibilities for women and girls, and increases in poverty and unemployment will all make it harder for women and girls to study.  These factors combine in harmful ways with pre-existing discriminatory gender norms, o...
Post a Comment
Read more

Iran, Russia Discussing Joint Production Of COVID-19 Vaccine

By Unknown
Iran and Russia's sovereign wealth fund RDIF are discussing the joint production of a vaccine against COVID-19, Russian news agencies cited the Iranian ambassador to Moscow as saying on Friday. "We are holding talks, I spoke with the head of RDIF Kirill Dmitriev, our officials have held several rounds of consultations and we announced that we will co-operate," Ambassador to Moscow Kazem Jalali was cited as saying. Thus far, Russia has struck a manufacturing partnership deal with India, which is due to produce 300 million doses of the 'Sputnik-V' vaccine domestically. It is also discussing such partnerships with several other countries, including Brazil.
Post a Comment
Read more

Covid - 19 Effect : Increased risks of violence against women and girls, exploitation and child marriage

By Unknown
In addition to dropping out of school, education disruption puts girls and young women at increased risk of numerous abuses: child marriage, exploitation, child labor, early pregnancy, and gender-based violence.  School closures, the loss of protective spaces provided by school, lockdowns spent at home and COVID-19 mitigation measures disrupt children›s routine, and place new stressors on parents and caregivers, contributing to an increase in the severity and frequency of domestic violence across the country. School closures represent the loss of a safe space, where girls who are experiencing violence and abuse can find respite, and where there is an opportunity for adults to identify signs of abuse and intervene in their lives. School closures and the socio-economic impact of COVID-19 have increased the risk of reliance on negative coping mechanisms, such as child marriage. With many families losing their means of livelihood, girls are at increased risk of being forced to drop...
Post a Comment
Read more